Patent details
EP2394656 Title: PHARMACEUTICAL FORMULATIONS COMPRISING THE PEPTIDE LIRAGLUTIDE AND PROPYLENE GLYCOL
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/01/2024
- Unitary Effect Status:
- Unitary Effect Request Withdrawn
- Request Unitary Effect Accepted:
- Unitary Effect Date:
- Unitary Effect Registration Date:
- Request Unitary Effect Rejected:
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Unitary Effect Request Withdrawal Date:
- 06/03/2024
- Unitary Effect request has been withdrawn
- UPP register:
- EP2394656
- SPC Number:
- Creation Date:
Basic Information
- Publication number:
- EP2394656
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Deemed not to be granted according to art. 52.4a or 52.6 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP11157594.0
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- Denmark (DK)
- Publications:
Dates
- Filing date:
- 18/11/2004
- Grant date:
- 13/12/2023
- EP Publication Date:
- 14/12/2011
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 13/12/2023
- EP B1 Publication Date:
- 13/12/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 17/11/2024
- Lapsed By Expiration Date:
- Revocation Date:
- Invalidity Date:
- 13/12/2023
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 13/12/2023
- Name:
- Novo Nordisk A/S
- Address:
- Novo Allé, 2880 BAGSVÆRD, Denmark (DK)
Inventor
1
- Name:
- Pedersen, Tina Bjeldskov
- Address:
- 2880 Bagsværd, Denmark (DK)
2
- Name:
- Bonde, Claude
- Address:
- 2880 Bagsværd, Denmark (DK)
3
- Name:
- Engelund, Dorthe Kot
- Address:
- 2880 Bagsværd, Denmark (DK)
Priority
- Priority Patent Number:
- 200301719
- Priority Date:
- 20/11/2003
- Priority Country:
- Denmark (DK)
Classification
- IPC or IDT classification:
- A61K 38/26; A61K 38/28; A61K 9/00; A61K 47/10; A61K 47/18; A61K 47/20; A61K 47/26; A61P 3/04; A61P 3/10; A61P 5/48; A61P 5/50;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 16/24
- Publication date:
- 17/04/2024
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- EP2
- Journal edition number:
- 50/23
- Publication date:
- 13/12/2023
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
1
- Issue number:
- 202416
- Publication date:
- 17/04/2024
- Description:
- Unitary Effect Request Withdrawal
2
- Issue number:
- 202407
- Publication date:
- 14/02/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202350
- Publication date:
- 13/12/2023
- Description:
- Grant (B1)
| Filing date | Document type | Document Description | Number of pages | File Type |
|---|